SCHEMBL27845784

SCHEMBL27845784

CS(=O)(=O)c1ccc(C2CNCCO2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8214932 0.84 DRD2 (0.47)
SCHEMBL7007529 0.84 SLC6A3 (0.49)
SCHEMBL322881 0.82 DRD2 (0.48)
SCHEMBL12609769 0.80
SCHEMBL12609765 0.80
SCHEMBL322953 0.78
SCHEMBL366065 0.78 DRD2 (0.53)
SCHEMBL322716 0.77 DRD2 (0.47)
SCHEMBL8911956 0.77 DRD2 (0.51)
SCHEMBL503067 0.76 DRD2 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137518-A As 6 inhibitor of histone deacetylase 1,3,4- oxadiazole derivatives compound and include its pharmaceutical composition 株式会社钟根堂 2018-06-08 CN disclosed
CN-102341108-B PHOSPHOINOSITIDE 3-KINASE INHIBITORS WITH ZINC BINDING MOIETY CURIS INC 2015-05-27 CN disclosed
CN-102970868-A Treatment of cancers having K-RAS mutations CURIS INC 2013-03-13 CN disclosed
CN-102341108-A PHOSPHOINOSITIDE 3-KINASE INHIBITORS WITH ZINC BINDING MOIETY CURIS INC 2012-02-01 CN disclosed